CORRECTION article

Front. Immunol., 30 April 2025

Sec. Vaccines and Molecular Therapeutics

Volume 16 - 2025 | https://doi.org/10.3389/fimmu.2025.1590490

This article is part of the Research TopicCommunity Series in Research Advances of Tuberculosis Vaccine and its Implication on COVID-19: Volume IIIView all 4 articles

Corrigendum: Enhancing cell-mediated immunity through dendritic cell activation: the role of Tri-GalNAc-modified PLGA-PEG nanoparticles encapsulating SR717

Yang Gong&#x;Yang Gong1†Hongbin Jia&#x;Hongbin Jia2†Wenrui DangWenrui Dang1Ting ZhouTing Zhou1Pu HePu He1Xiaolei Wang,*Xiaolei Wang2,3*Bingdong Zhu,*Bingdong Zhu1,3*
  • 1State Key Laboratory for Animal Disease Control and Prevention & Lanzhou Center for Tuberculosis Research, Institute of Pathogen Biology, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China
  • 2State Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou, China
  • 3College of Veterinary Medicine, Lanzhou University, Lanzhou, China

A Corrigendum on
Enhancing cell-mediated immunity through dendritic cell activation: the role of Tri-GalNAc-modified PLGA-PEG nanoparticles encapsulating SR717

by Gong Y, Jia H, Dang W, Zhou T, He P, Wang X and Zhu B (2024). Front. Immunol. 15:1490003. doi: 10.3389/fimmu.2024.1490003

In the published article, there was an error in Supplementary Figure S1. A portion of the content in Supplementary Figure S1 is missing.

In the published article, there was an error in Supplementary Figure S2. A portion of the content in Supplementary Figure S2 is incorrect.

In the published article, there was an error in Supplementary Figure S4. The group names in both the image and the figure legend of Supplementary Figure S4 are incorrect.

In the published article, there was an error in Supplementary Figure S5. The group names in both the image and the figure legend of Supplementary Figure S5 are incorrect.

The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: adjuvant, dendritic cells, Tri-GalNAc, SR717, PLGA-PEG nanoparticles, tuberculosis

Citation: Gong Y, Jia H, Dang W, Zhou T, He P, Wang X and Zhu B (2025) Corrigendum: Enhancing cell-mediated immunity through dendritic cell activation: the role of Tri-GalNAc-modified PLGA-PEG nanoparticles encapsulating SR717. Front. Immunol. 16:1590490. doi: 10.3389/fimmu.2025.1590490

Received: 09 March 2025; Accepted: 15 April 2025;
Published: 30 April 2025.

Edited and Reviewed by:

Wenping Gong, The 8th Medical Center of PLA General Hospital, China

Copyright © 2025 Gong, Jia, Dang, Zhou, He, Wang and Zhu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Bingdong Zhu, YmR6aHVAbHp1LmVkdS5jbg==; Xiaolei Wang, d2FuZ3hpYW9sZWlAbHp1LmVkdS5jbg==

These authors contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.